Moors & Cabot Inc. Boosts Stake in Healthpeak Properties, Inc. (NYSE:DOC)

Moors & Cabot Inc. increased its position in Healthpeak Properties, Inc. (NYSE:DOC) by 8.4% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 27,093 shares of the real estate investment trust’s stock after purchasing an additional 2,101 shares during the quarter. Moors & Cabot Inc.’s holdings in Healthpeak Properties were worth $549,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. State Street Corp bought a new position in Healthpeak Properties in the third quarter worth $1,093,576,000. JPMorgan Chase & Co. grew its position in shares of Healthpeak Properties by 23.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock worth $493,115,000 after buying an additional 4,056,931 shares during the period. Principal Financial Group Inc. increased its stake in shares of Healthpeak Properties by 2,113.5% in the 4th quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust’s stock worth $367,575,000 after acquiring an additional 17,314,572 shares in the last quarter. Geode Capital Management LLC purchased a new position in Healthpeak Properties during the 3rd quarter valued at about $403,898,000. Finally, Charles Schwab Investment Management Inc. boosted its stake in Healthpeak Properties by 0.5% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 10,153,450 shares of the real estate investment trust’s stock worth $205,810,000 after acquiring an additional 53,392 shares in the last quarter. 93.57% of the stock is currently owned by institutional investors.

Healthpeak Properties Trading Up 2.1 %

Shares of DOC stock opened at $20.45 on Friday. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96. Healthpeak Properties, Inc. has a 12-month low of $16.66 and a 12-month high of $23.26. The stock has a market capitalization of $14.30 billion, a P/E ratio of 58.42, a P/E/G ratio of 2.17 and a beta of 1.14. The firm’s 50 day moving average is $20.21 and its 200 day moving average is $21.24.

Healthpeak Properties Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Friday, February 14th were issued a dividend of $0.305 per share. This represents a $1.22 annualized dividend and a dividend yield of 5.97%. This is a boost from Healthpeak Properties’s previous quarterly dividend of $0.30. The ex-dividend date of this dividend was Friday, February 14th. Healthpeak Properties’s dividend payout ratio is 348.57%.

Analyst Upgrades and Downgrades

DOC has been the subject of several recent research reports. Scotiabank lowered their target price on shares of Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating for the company in a report on Friday, February 28th. Wells Fargo & Company lowered their price objective on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 10th. Morgan Stanley raised Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 target price on the stock in a research note on Wednesday, January 15th. Mizuho reduced their price target on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a report on Thursday, December 5th. Finally, Wedbush dropped their price target on shares of Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday, February 14th. Four analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $23.92.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.